Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
14 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/14/3042961/31499/en/Gradalis-Announces-Development-of-Clinically-Relevant-Exome-Sequencing-Bioinformatics-Pipeline-to-Determine-Clonal-Tumor-Mutation-Burden.html
05 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/05/3021053/31499/en/Gradalis-Secures-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-Vigil-Gemogenovatucel-T-An-Investigational-Personalized-Immunotherapy-for-Advanced-Ovarian-Cancer.html
04 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/04/2804387/0/en/Gradalis-GRAD1405-bi-shRNAi-Candidate-First-to-Show-Positive-Impact-on-Three-Key-KRAS-Mutations-Identified-in-Drug-Resistant-Lung-Colon-and-Pancreatic-Cancers.html
05 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/12/05/2790847/0/en/Gradalis-Highlights-Importance-of-Targeting-Clonal-Neoantigens-in-Achieving-Durable-Benefit-in-Cancer-Treatment.html
16 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/16/2782211/0/en/Gradalis-Awarded-9-9-Million-Grant-From-the-Cancer-Prevention-and-Research-Institute-of-Texas.html
18 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/18/2762277/0/en/Gradalis-to-Host-Virtual-KOL-Discussion-on-the-Vigil-Platform-Entering-Phase-2-for-Platinum-Sensitive-Recurrent-Ovarian-Cancer-on-October-25-2023.html
ABOUT THIS PAGE